ArticleTherapeutic advances in medical oncology2026
Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with
Hiroyuki Kodama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.